TELA Bio Inc
NASDAQ:TELA

Watchlist Manager
TELA Bio Inc Logo
TELA Bio Inc
NASDAQ:TELA
Watchlist
Price: 0.9589 USD -2.15%
Market Cap: $42m

Relative Value

The Relative Value of one TELA stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.9589 USD, TELA Bio Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TELA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

TELA Competitors Multiples
TELA Bio Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
TELA Bio Inc
NASDAQ:TELA
38.7m USD 0.5 -1 -1.5 -1.4
JP
Hoya Corp
TSE:7741
8.7T JPY 9.7 41.5 25.7 30.8
CH
Alcon AG
SIX:ALC
30.9B CHF 3.8 37.4 19.6 38.1
US
Medline Inc
NASDAQ:MDLN
35.4B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
121.3B DKK 4.3 33.3 15.4 18.3
US
Align Technology Inc
NASDAQ:ALGN
11.6B USD 2.9 30.7 13.9 17.7
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.3 17.7 28.7
KR
HLB Inc
KOSDAQ:028300
8.8T KRW 99.1 -36.4 -90.9 -86
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY 9.5 26.1 23.4 23.4
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.5 19.4 91.8
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF 5.3 21.5 13.9 18.9
P/E Multiple
Earnings Growth PEG
US
TELA Bio Inc
NASDAQ:TELA
Average P/E: 31.4
Negative Multiple: -1
N/A N/A
JP
Hoya Corp
TSE:7741
41.5
13%
3.2
CH
Alcon AG
SIX:ALC
37.4
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.3
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
30.7
27%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
29.3
33%
0.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.4 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.1
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.5 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.5
32%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
TELA Bio Inc
NASDAQ:TELA
Average EV/EBITDA: 18.6
Negative Multiple: -1.5
N/A N/A
JP
Hoya Corp
TSE:7741
25.7
11%
2.3
CH
Alcon AG
SIX:ALC
19.6
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.4
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
13.9
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
17.7
10%
1.8
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -90.9 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.4
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.4
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.9
21%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
TELA Bio Inc
NASDAQ:TELA
Average EV/EBIT: 33.5
Negative Multiple: -1.4
N/A N/A
JP
Hoya Corp
TSE:7741
30.8
N/A N/A
CH
Alcon AG
SIX:ALC
38.1
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.3
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
17.7
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
28.7
22%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -86 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.4
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
91.8
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
18.9
29%
0.7